Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Capital Expenditures

Alexion Pharm Inc Capital Expenditures Chart (ALXN)

Alexion Pharm Inc annual/quarterly Capital Expenditures from 2010 to 2020.
  • Alexion Pharm Inc Capital Expenditures for the quarter ending September 09, 2020 was $-11m a -177.78% increase of 19m year over year
  • Alexion Pharm Inc Capital Expenditures for the last 12 months ending September 09, 2020 was $-59m a -161.32% increase of 96m year over year
  • Alexion Pharm Inc Annual Capital Expenditures for 2019 was $-155m a -37.69% increase of 58m from 2018
  • Alexion Pharm Inc Annual Capital Expenditures for 2018 was $-213m a -67.75% increase of 144m from 2017
  • Alexion Pharm Inc Annual Capital Expenditures for 2017 was $-357m a 6.88% decrease of -25m from 2016
Other Cash Flow Metrics:
  • Alexion Pharm Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $387m a 33.45% increase of 130m year over year
  • Alexion Pharm Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $227m a 35.57% increase of 81m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN Capital Expenditures Data

09/2020$-11m
06/2020$-6m
03/2020$-12m
12/2019$-30m
09/2019$-42m
06/2019$-47m
03/2019$-36m
12/2018$-42m
09/2018$-41m
06/2018$-63m

Annual ALXN Capital Expenditures Data

2019$-155m
2018$-213m
2017$-357m
2016$-333m
2015$-286m
2014$-137m
2013$-29m
2012$-22m
2011$-22m
2010$-13m